en
Scientific article
Open access
English

Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study

Published inJournal of acquired immune deficiency syndromes, vol. 69, no. 4, p. 413-421
Publication date2015-08-01
Abstract

Background: Patients with HIV exposed to the antiretroviral drug abacavir may have an increased risk of cardiovascular disease (CVD). There is concern that this association arises because of a channeling bias. Even if exposure is a risk, it is not clear how that risk changes as exposure cumulates.

Methods: We assess the effect of exposure to abacavir on the risk of CVD events in the Swiss HIV Cohort Study. We use a new marginal structural Cox model to estimate the effect of abacavir as a flexible function of past exposures while accounting for risk factors that potentially lie on a causal pathway between exposure to abacavir and CVD.

Results: A total of 11,856 patients were followed for a median of 6.6 years; 365 patients had a CVD event (4.6 events per 1000 patient-years). In a conventional Cox model, recent--but not cumulative--exposure to abacavir increased the risk of a CVD event. In the new marginal structural Cox model, continued exposure to abacavir during the past 4 years increased the risk of a CVD event (hazard ratio = 2.06; 95% confidence interval: 1.43 to 2.98). The estimated function for the effect of past exposures suggests that exposure during the past 6-36 months caused the greatest increase in risk.

Conclusions: Abacavir increases the risk of a CVD event: the effect of exposure is not immediate, rather the risk increases as exposure cumulates over the past few years. This gradual increase in risk is not consistent with a rapidly acting mechanism, such as acute inflammation.

eng
Keywords
  • Adult
  • Anti-HIV Agents / administration & dosage
  • Anti-HIV Agents / therapeutic use
  • Cardiovascular Diseases / chemically induced
  • Dideoxynucleosides / adverse effects
  • Dideoxynucleosides / therapeutic use
  • Female
  • HIV Infections / drug therapy
  • HIV Infections / epidemiology
  • Humans
  • Male
  • Middle Aged
  • Switzerland / epidemiology
Research group
Citation (ISO format)
YOUNG, Jim et al. Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort Study. In: Journal of acquired immune deficiency syndromes, 2015, vol. 69, n° 4, p. 413–421. doi: 10.1097/QAI.0000000000000662
Main files (1)
Article (Accepted version)
accessLevelPublic
Identifiers
ISSN of the journal1525-4135
26views
5downloads

Technical informations

Creation02/07/2023 8:41:01 AM
First validation11/20/2023 4:57:30 PM
Update time11/20/2023 4:57:30 PM
Status update11/20/2023 4:57:30 PM
Last indexation05/06/2024 5:26:16 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack